Quick Answer
Evolent Health, Inc. reported Cash and Equivalents of $151.86 million for fiscal year 2025.
Evolent Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $151.86M | +45.7% |
| 2024 | $104.20M | -46.0% |
| 2023 | $192.82M | +2.5% |
| 2022 | $188.20M | -29.3% |
| 2021 | $266.28M | -16.5% |
| 2020 | $319.00M | +215.8% |
| 2019 | $101.01M | -55.8% |
| 2018 | $228.32M | -4.2% |
| 2017 | $238.43M | +77.2% |
| 2016 | $134.56M | -7.7% |
| 2015 | $145.73M | — |
| 2014 | $0.00 | — |
| 2013 | $0.00 | -100.0% |
| 2012 | $5.25M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $116.65M | +20.8% | -22.7% |
| June 30, 2025 | $151.00M | +49.1% | -38.8% |
| March 31, 2025 | $246.55M | +49.3% | +136.6% |
| December 31, 2024 | $104.20M | -46.0% | +7.9% |
| September 30, 2024 | $96.58M | -47.7% | -4.6% |
| June 30, 2024 | $101.25M | -29.0% | -38.7% |
| March 31, 2024 | $165.15M | +4.8% | -14.4% |
| December 31, 2023 | $192.82M | +2.5% | +4.5% |
- Evolent Health, Inc. showed an increase of +45.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2012–2025 period, Evolent Health, Inc.’s cash and equivalents has grown by 2791.4% (from $5.25 million to $151.86 million).
- The most recent figure is from Evolent Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: